BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19644906)

  • 21. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses.
    Bretterklieber A; Painsi C; Avian A; Wutte N; Aberer E
    BMC Res Notes; 2014 Sep; 7():594. PubMed ID: 25183055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of psychological functioning upon systemic sclerosis patients' quality of life.
    Hyphantis TN; Tsifetaki N; Siafaka V; Voulgari PV; Pappa C; Bai M; Palieraki K; Venetsanopoulou A; Mavreas V; Drosos AA
    Semin Arthritis Rheum; 2007 Oct; 37(2):81-92. PubMed ID: 17512572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis.
    Lumetti F; Barone L; Alfieri C; Silva M; Serra V; Delsante G; Sverzellati N; Ariani A
    Acta Biomed; 2015 Sep; 86(2):142-8. PubMed ID: 26422428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey.
    Nguyen C; Ranque B; Baubet T; Bérezné A; Mestre-Stanislas C; Rannou F; Papelard A; Morell-Dubois S; Revel M; Moro MR; Guillevin L; Poiraudeau S; Mouthon L;
    PLoS One; 2014; 9(2):e90484. PubMed ID: 24587375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
    Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
    Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
    Sekhon S; Pope J; ; Baron M
    J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of poor mental health in adult spinal deformity patients with poor physical function: a retrospective analysis with a 2-year follow-up.
    Bakhsheshian J; Scheer JK; Gum JL; Hostin R; Lafage V; Bess S; Protopsaltis TS; Burton DC; Keefe MK; Hart RA; Mundis GM; Shaffrey CI; Schwab F; Smith JS; Ames CP;
    J Neurosurg Spine; 2017 Jan; 26(1):116-124. PubMed ID: 27541847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes.
    de Achaval S; Kallen MA; Mayes MD; Lopez-Olivo MA; Suarez-Almazor ME
    J Rheumatol; 2013 Aug; 40(8):1337-43. PubMed ID: 23772081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy.
    Quartuccio L; Isola M; Masolini P; Scaini P; Zani R; Tavoni A; Pietrogrande M; Bombardieri S; De Vita S
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S9-14. PubMed ID: 23044040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease.
    Iudici M; Cuomo G; Vettori S; Avellino M; Valentini G
    Health Qual Life Outcomes; 2013 Feb; 11():23. PubMed ID: 23442975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey.
    Salaffi F; Sarzi-Puttini P; Girolimetti R; Atzeni F; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S67-74. PubMed ID: 20074443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.
    Khanna D; Furst DE; Wong WK; Tsevat J; Clements PJ; Park GS; Postlethwaite AE; Ahmed M; Ginsburg S; Hays RD;
    Qual Life Res; 2007 Aug; 16(6):1083-92. PubMed ID: 17404896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR; Glaman DD; Schentag CT; Lee P
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.
    Danieli E; Airò P; Bettoni L; Cinquini M; Antonioli CM; Cavazzana I; Franceschini F; Cattaneo R
    Clin Rheumatol; 2005 Feb; 24(1):48-54. PubMed ID: 15300468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Music Interventions With Health-Related Quality of Life: A Systematic Review and Meta-analysis.
    McCrary JM; Altenmüller E; Kretschmer C; Scholz DS
    JAMA Netw Open; 2022 Mar; 5(3):e223236. PubMed ID: 35315920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of SLE on health-related quality of life assessed with SF-36: a systemic review and meta-analysis.
    Gu M; Cheng Q; Wang X; Yuan F; Sam NB; Pan H; Li B; Ye D
    Lupus; 2019 Mar; 28(3):371-382. PubMed ID: 30813871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluations and analyses of quality of life in 90 patients with systemic sclerosis by health assessment questionnaire-disability index].
    Mao X; Sun Q
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3471-4. PubMed ID: 25622735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatigue in systemic sclerosis: a systematic review.
    Basta F; Afeltra A; Margiotta DPE
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):150-160. PubMed ID: 29303706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of rheumatoid arthritis on the burden of disease in urban China.
    Langley PC; Mu R; Wu M; Dong P; Tang B
    J Med Econ; 2011; 14(6):709-19. PubMed ID: 21899486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.